WO1999038866A8 - Derives de 8-azabicyclo[3.2.1]oct-2-ene sous forme marquee et utilisation de derives de 8-azabicyclo[3.2.1]oct-2-ene sous forme marquee ou non marquee - Google Patents

Derives de 8-azabicyclo[3.2.1]oct-2-ene sous forme marquee et utilisation de derives de 8-azabicyclo[3.2.1]oct-2-ene sous forme marquee ou non marquee

Info

Publication number
WO1999038866A8
WO1999038866A8 PCT/DK1999/000044 DK9900044W WO9938866A8 WO 1999038866 A8 WO1999038866 A8 WO 1999038866A8 DK 9900044 W DK9900044 W DK 9900044W WO 9938866 A8 WO9938866 A8 WO 9938866A8
Authority
WO
WIPO (PCT)
Prior art keywords
labelled
azabicyclo
oct
ene derivatives
derivatives
Prior art date
Application number
PCT/DK1999/000044
Other languages
English (en)
Other versions
WO1999038866A1 (fr
Inventor
Peter Moldt
Joergen Scheel-Krueger
Elsebet Oestergaard Nielsen
Original Assignee
Neurosearch As
Peter Moldt
Scheel Krueger Joergen
Elsebet Oestergaard Nielsen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As, Peter Moldt, Scheel Krueger Joergen, Elsebet Oestergaard Nielsen filed Critical Neurosearch As
Priority to EP99906069A priority Critical patent/EP1068204A1/fr
Priority to JP2000529334A priority patent/JP2002501921A/ja
Priority to AU26099/99A priority patent/AU2609999A/en
Publication of WO1999038866A1 publication Critical patent/WO1999038866A1/fr
Publication of WO1999038866A8 publication Critical patent/WO1999038866A8/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des dérivés de 8-azabicyclo[3.2.1]oct-2-ène sous leur forme marquée. L'invention concerne, en outre, l'utilisation desdits dérivés sous leur forme marquée ou non marquée lors de diagnostics, plus particulièrement lors d'imagerie de récepteurs in vivo (neuro-imagerie)
PCT/DK1999/000044 1998-01-28 1999-01-28 Derives de 8-azabicyclo[3.2.1]oct-2-ene sous forme marquee et utilisation de derives de 8-azabicyclo[3.2.1]oct-2-ene sous forme marquee ou non marquee WO1999038866A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP99906069A EP1068204A1 (fr) 1998-01-28 1999-01-28 Derives de 8-azabicyclo 3.2.1]oct-2-ene sous forme marquee et utilisation de derives de 8-azabicyclo 3.2.1]oct-2-ene sous forme marquee ou non marquee
JP2000529334A JP2002501921A (ja) 1998-01-28 1999-01-28 標識された形での８−アザビシクロ［３．２．１］オクト−２−エン誘導体及び標識された及び標識されていない形での８−アザビシクロ［３．２．１］オクト−２−エン誘導体の使用方法
AU26099/99A AU2609999A (en) 1998-01-28 1999-01-28 8-azabicyclo(3.2.1)oct-2-ene derivatives in labelled and use of 8-azabicyclo(3.2.1)oct-2-ene derivatives in labelled and unlabelled form

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK0125/98 1998-01-28
DK12598 1998-01-28

Publications (2)

Publication Number Publication Date
WO1999038866A1 WO1999038866A1 (fr) 1999-08-05
WO1999038866A8 true WO1999038866A8 (fr) 1999-10-28

Family

ID=8090037

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK1999/000044 WO1999038866A1 (fr) 1998-01-28 1999-01-28 Derives de 8-azabicyclo[3.2.1]oct-2-ene sous forme marquee et utilisation de derives de 8-azabicyclo[3.2.1]oct-2-ene sous forme marquee ou non marquee

Country Status (5)

Country Link
EP (1) EP1068204A1 (fr)
JP (1) JP2002501921A (fr)
AU (1) AU2609999A (fr)
WO (1) WO1999038866A1 (fr)
ZA (1) ZA99681B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE258176T1 (de) 1999-01-28 2004-02-15 Neurosearch As Neue azabicyclo derivate und ihre verwendung
US7307087B2 (en) * 2000-10-13 2007-12-11 Neurosearch A/S Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128118A (en) * 1990-08-09 1992-07-07 Research Triangle Institute Cocaine receptor binding ligands
GB9019973D0 (en) * 1990-09-12 1990-10-24 Wyeth John & Brother Ltd Azabicyclic derivatives
KR100251339B1 (ko) * 1991-11-15 2000-09-01 제임스 씨. 하이트 코카인 수용체 결합 리간드
AU672052B2 (en) * 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds
FI96603C (fi) * 1994-12-30 1996-07-25 Joergen Bergman Uusi radioisotoopilla leimattu yhdiste, yhdistettä sisältävä seos sekä menetelmä niiden valmistamiseksi
DK0859777T3 (da) * 1995-10-13 2007-09-03 Neurosearch As 8-azabicyclo[3.2.1]oct-2-en-derivater, deres fremstilling og anvendelse
US5726189A (en) * 1996-05-03 1998-03-10 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Method for imaging nicotinic acetylcholinergic receptors in the brain using radiolabeled pyridyl-7-azabicyclo 2.2.1!heptanes
GB9706222D0 (en) * 1997-03-26 1997-05-14 Zeneca Ltd Bicyclic amine derivatives

Also Published As

Publication number Publication date
EP1068204A1 (fr) 2001-01-17
AU2609999A (en) 1999-08-16
ZA99681B (en) 1999-09-27
JP2002501921A (ja) 2002-01-22
WO1999038866A1 (fr) 1999-08-05

Similar Documents

Publication Publication Date Title
SG113402A1 (en) Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
IL130058A0 (en) 8-Azabicyclo(3.2.1)octane-8-azabicyclo(3.2.1)oct-6-ene-9-azabicyclo(3.3.1)nonane-9-aza-3-oxabicyclo (3.3.1)nonane- and 9-aza-3-thiabicyclo(3.3.1)nonane derivatives their preparation and their use as insecticides
HUP9802433A3 (en) 8-azabicyclo[3.2.1]oct-2-ene derivatives, their preparation and use
AU4789197A (en) 8-azabicyclo{3.2.1}octane-, 8-azabicyclo{3.2.1}oct-6-ene-, 9-azabicyclo{3.3.1}nonane-, 9-aza-3-oxabicyclo{3.3.1}nonane-, 9-aza-3-thiabicyclo{3.3.1}nonane derivatives, their preparation and their use as insecticides
ZA987540B (en) Process for the preparation of stanol esters, and use thereof.
CA2258153A1 (fr) Agonistes de recepteur du facteur de croissance des hepatocytes et utilisation desdits agonistes
HUP0002713A3 (en) 8-azabicyclo[3,2,1]oct-2-ene and octane derivatives, process for preparation thereof, pharmaceutical compositions comprising thereof and their use
HK1033582A1 (en) Antibodies to death receptor 4 (dr4) and uses thereof
AU3551997A (en) Substituted triazolo pyridazine derivatives as inverse agonists of the GABAAalpha5 receptor subtype
HUP0102470A3 (en) 1,3-azole derivatives as retinoid-associated receptor regulators and their use
IL147977A0 (en) Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
ZA978081B (en) 3-Substituted pyrido ¬4&#39;,3&#39;:4,5¾thieno¬2,3-d¾pyrimidine derivatives the preparation and use thereof
HUP0004020A3 (en) Tricyclic triazolobenzazepine derivatives, process for producing the same, and their use as antiallergic agent
GR3033415T3 (en) (Aminoalkyl- and acylaminoalkyl-oxy)benzyloxyquinolines, process for their preparation and use as Bradykinin receptor antagonists
AU2278700A (en) Novel azabicyclo derivatives and their use
HK1017899A1 (en) Process for the preparation of 17-esters of 9alpha,21-dihalo-pregnane-11beta,17alphadiol-20-ones
WO1999038866A8 (fr) Derives de 8-azabicyclo[3.2.1]oct-2-ene sous forme marquee et utilisation de derives de 8-azabicyclo[3.2.1]oct-2-ene sous forme marquee ou non marquee
IL135520A0 (en) 8-azabicyclo [3.2.1.] octane-3-methanamine derivatives, their preparation and their therapeutic application
HUP0100542A3 (en) Progestogen and antiprogestogen containing kit, process for its preparation and use of the compounds for the preparation of contraseptives
HUT68293A (en) 5-ht antagonists as acting agent against cerebrovascular deseases
ZA988397B (en) Process for the preparation of substituted 5,6-dihydro-2H-pyran-2-ones
IL119868A0 (en) Process for the preparation of 4,4&#39;-oxybisphthalic dianhydride
IL135923A0 (en) Process for the preparation of 8-azabicyclo (3.2.1) octane derivatives
GB9715018D0 (en) 3-Fluoro-4-aminopiperidine derivatives as 5-HT receptor agonists
AU1442099A (en) Process for the preparation of substituted 8-azabicyclo{3.2.1}octanes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 31/99 UNDER (54) THE TITLE IN ENGLISH SHOULD READ "8-AZABICYCLO (3.2.1) OCT-2-ENE DERIVATIVES IN LABELLED FORM AND USE OF 8-AZABICYCLO (3.2.1) OCT-2-ENE DERIVATIVES IN LABELLED AND UNLABELLED FORM"

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 09521430

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1999906069

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1999906069

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1999906069

Country of ref document: EP